Avista in $350m pharma exit
The firm has sold biopharmaceutical testing company BioReliance, which it acquired in 2007 for $210m.
The firm has sold biopharmaceutical testing company BioReliance, which it acquired in 2007 for $210m.
Copyright PEI Media
Not for publication, email or dissemination